The CDC estimates there are over 68 million Sexually transmitted infections (STIs) in the U.S., with 26 million new cases each year. STIs are often associated with stigma, shame, and fear, which can prevent people from seeking testing and treatment. This stigma can lead to increased transmission rates, particularly in marginalized communities.
Annually, Americans visit their pharmacy 35 times versus four times at their primary care provider. Pharmacists are well-positioned to help destigmatize STIs and improve health outcomes through education, counseling, testing, and even treatment in some states.
With expertise in medications and healthcare, pharmacists can educate patients about the risks and symptoms of STIs and prevention methods as well as discuss the benefits of testing and treatment.
Several states have authorized pharmacists to prescribe pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to qualifying individuals to prevent new HIV infections.
In addition to education and counseling, pharmacists can play a crucial role in providing access to STI testing and treatment.
Many pharmacies now offer rapid STI testing kits, which can provide results within minutes.
Pharmacists stand at the forefront of comprehensive STI care. Their knowledge extends to educating patients about proper medication usage, potential side effects, and the importance of adherence to treatment plans.